A Model for Predoctoral Psychopharmacology Training: Shaping a New Frontier in Clinical Psychology

Professional Psychology: Research and Practice

Volumn 35, Issue 2, 2004, Pages 151-157

  Tulkin, Steven R ^a   Stock, Wendy ^a  

^a ALLIANT INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842843046     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.35.2.151     Document Type: Article

References (24)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
2. American Psychological Association. (1996). Recommended postdoctoral training in psychopharmacology for prescription privileges, Washington, DC: Author.
3. Bates, D. W., Boyle, D. L., Vander Vliet, M. B., Schneider, J., & Leape, L. (1995). Relationship between medication errors and adverse drug events. Journal of General Internal Medicine, 10, 199-205.
4. Beardsley, R. S., Gardocki, G. J., Larson, D. B., & Hildago, J. (1988). Prescribing of psychotropic medication by primary care physicians and psychiatrists. Archives of General Psychiatry, 45, 1117-1119.
5. Beutler, L. E. (2002). Prescriptive authority: Moving toward a new clinical psychology? The Clinical Psychologist, 55, 1-3.
6. Board of Psychology, State of California Consumer Affairs. (2003). Laws and regulations relating to the practice of psychology, business and professions code. Sacramento, CA: Author.
7. Caccavale, J., & Wiggins, J. (2002). Patient safety and adverse psychotropic drug events: Psychology and medicine. Unpublished manuscript.
8. Committee on Quality of Health Care in America: Institute of Medicine. (2000). To err is human: Building a safer health system. Washington, DC: National Academy Press.
9. Council of University Directors of Clinical Psychology. (2001). Report of the CUDCP Task Force evaluating the effect of Level 3 training in prescription privileges upon the scientist-practitioner. Washington, DC: Author.
10. De La Cancela, V. (2000). Diversity in psychopharmacology and pharmacotherapy. Public Service Psychology, 25(3), 16.
11. DeLeon, P. H., Kurpius, S. E. R., & Sexton, J. L. (2001). Prescriptive authority for psychologists: Law, ethics, and public policy. In M. T. Sammons & N. B. Schmidt (Eds.), Combined treatments for mental disorders: A guide to psychological and pharmacological interventions (pp. 33-52). Washington, DC: American Psychological Association.
12. Fox, R. E., Schwelitz, F. D., & Barclay, A. G. (1992). A proposed curriculum for psychopharmacology training for professional psychologists. Professional Psychology: Research and Practice, 23, 216-219.
13. Hohagen, F., Winkelmann, G., Rasche-Rauchle, H. I., Honig, A., Munchau, N., Hiss, H., et al. (1998). Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo: Results of a multicenter study. British Journal of Psychiatry, 173(Suppl. 35S), 71-78.
14. Leape, L. L., Bates, D. W., Cullen, D. J., Cooper, J., Demonaco, H., Gallivan, T., et al. (1995). Systems analysis of adverse drug events. JAMA, 274, 35-43.
15. Lin, K., Poland, R., & Nakasaki, G. (Eds.). (1993). Psychopharmacology and psychobiology of ethnicity. Washington, DC: American Psychiatric Press.
16. McDaniel, S. H., Belar, C. D., Schroeder, C., Hargrove, D. S., & Freeman, E. L. (2002). A training curriculum for professional psychologists in primary care. Professional Psychology: Research and Practice, 33, 65-72.
17. McGrath, R. E., Wiggins, J. G., Sammons, M. T., Levant, R. F., Brown, A., & Stock, W. (2004). Professional issues in psychopharmacology for psychologists. Professional Psychology: Research and Practice, 35, 158-163.
18. Morrison, J. (1997). When psychological problems mask medical disorders. New York: Guilford Press.
19. Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., & Magno Zito, J. (1998). Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialties. JAMA, 279, 526-531.
20. Sammons, M. T., Gorny, S. W., Zinner, E. S., & Allen, R. P. (2000). Prescriptive authority for psychologists: A consensus of support. Professional Psychology: Research and Practice, 31, 604-609.
21. Sammons, M. T., & Schmidt, N. B. (2001). Introduction: Toward a psychological model of pharmacological service provision. In M. T. Sammons & N. B. Schmidt (Eds.), Combined treatments for mental disorders: A guide to psychological and pharmacological interventions (pp. 3-10). Washington, DC: American Psychological Association.
22. Sammons, M. T., Sexton, J. L., & Meredith, J. M. (1996). Basic science training in psychopharmacology: How much is enough? American Psychologist, 51, 230-234.
23. Smyer, M. A., Balster, R. L., Egli, D., Johnson, D. L., Kilbey, M. M., Leith, N. J., & Puente, A. E. (1993). Summary of the report of the Ad Hoc Task Force on Psychopharmacology of the American Psychological Association. Professional Psychology: Research and Practice, 24, 394-403.
24. Zelman, D., & Stock, W. (2000). Creating a feminist psychopharmacology. Public Service Psychology, 25(3), 16.